// App-Quantinova.ai

7039 : A Universal Suicide Switch for Chimeric Antigen Receptor T cell Adoptive Therapies.

Researchers

Presenter

  • Julianne Smith

Principal Investigators

  • Julien Valton

Medical Centers

  • Cellectis, Paris, France

  • Cellectis.Inc, New York, NY

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved